Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
O'Connor AE, Gallagher WM, Byrne AT. O'Connor AE, et al. Among authors: gallagher wm. Photochem Photobiol. 2009 Sep-Oct;85(5):1053-74. doi: 10.1111/j.1751-1097.2009.00585.x. Epub 2009 Aug 3. Photochem Photobiol. 2009. PMID: 19682322 Review.
Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour.
Killoran J, Allen L, Gallagher JF, Gallagher WM, O'Shea DF. Killoran J, et al. Among authors: gallagher jf, gallagher wm. Chem Commun (Camb). 2002 Sep 7;(17):1862-3. doi: 10.1039/b204317c. Chem Commun (Camb). 2002. PMID: 12271646
Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells.
Doorty KB, Golubeva TA, Gorelov AV, Rochev YA, Allen LT, Dawson KA, Gallagher WM, Keenan AK. Doorty KB, et al. Among authors: gallagher wm. Cardiovasc Pathol. 2003 Mar-Apr;12(2):105-10. doi: 10.1016/s1054-8807(02)00165-5. Cardiovasc Pathol. 2003. PMID: 12684168
In vitro demonstration of the heavy-atom effect for photodynamic therapy.
Gorman A, Killoran J, O'Shea C, Kenna T, Gallagher WM, O'Shea DF. Gorman A, et al. Among authors: gallagher wm. J Am Chem Soc. 2004 Sep 1;126(34):10619-31. doi: 10.1021/ja047649e. J Am Chem Soc. 2004. PMID: 15327320
Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride.
Tacke M, Cuffe LP, Gallagher WM, Lou Y, Mendoza O, Müller-Bunz H, Rehmann FJ, Sweeney N. Tacke M, et al. Among authors: gallagher wm. J Inorg Biochem. 2004 Dec;98(12):1987-94. doi: 10.1016/j.jinorgbio.2004.09.001. J Inorg Biochem. 2004. PMID: 15541486
A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia.
Gallagher WM, Allen LT, O'Shea C, Kenna T, Hall M, Gorman A, Killoran J, O'Shea DF. Gallagher WM, et al. Br J Cancer. 2005 May 9;92(9):1702-10. doi: 10.1038/sj.bjc.6602527. Br J Cancer. 2005. PMID: 15841085 Free PMC article.
Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.
Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher WM. Brennan DJ, et al. Among authors: gallagher wm. Expert Opin Biol Ther. 2005 Aug;5(8):1069-83. doi: 10.1517/14712598.5.8.1069. Expert Opin Biol Ther. 2005. PMID: 16050784 Review.
Supramolecular photonic therapeutic agents.
McDonnell SO, Hall MJ, Allen LT, Byrne A, Gallagher WM, O'Shea DF. McDonnell SO, et al. Among authors: gallagher wm. J Am Chem Soc. 2005 Nov 30;127(47):16360-1. doi: 10.1021/ja0553497. J Am Chem Soc. 2005. PMID: 16305199
Heteroaryl substituted titanocenes as potential anti-cancer drugs.
Sweeney N, Gallagher WM, Müller-Bunz H, Pampillón C, Strohfeldt K, Tacke M. Sweeney N, et al. Among authors: gallagher wm. J Inorg Biochem. 2006 Sep;100(9):1479-86. doi: 10.1016/j.jinorgbio.2006.04.006. Epub 2006 Apr 29. J Inorg Biochem. 2006. PMID: 16764931
Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D, Gallagher W, Bennett DC. Easty D, et al. Curr Cancer Drug Targets. 2006 Sep;6(6):519-32. doi: 10.2174/156800906778194603. Curr Cancer Drug Targets. 2006. PMID: 17017875 Review.
207 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page